Increased red cell sodium-lithium countertransport and lymphocyte cytosolic calcium are separate phenotypes in patients with essential hypertension-Reference-Cited by-同舟云学术

Increased red cell sodium-lithium countertransport and lymphocyte cytosolic calcium are separate phenotypes in patients with essential hypertension

Published:2002-05 Issue:5 Volume:16 Page:353-358
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Romero J R,Rivera A,Monari A,Ceolotto G,Semplicini A,Conlin P R

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001387.pdf

Reference29 articles.

1. Canessa M et al. Increased sodium-lithium countertransport in red cells ofpatients with essential hypertension N Engl J Med 1980; 302: 772–776

2. Strazzullo P et al. Red blood cell sodium-lithium countertransport and risk of future hypertension: the Olivetti Prospective Heart Study Hypertension 1998; 31: 1284–1289

3. Laurenzi M et al. Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio Population Study Circulation 1997; 95: 581–587

4. Doria A et al. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension Am J Physiol 1991; 26: E684–E691

5. Zerbini G et al. Sodium-lithium countertransport has low affinity in hyperinsulinemic hypertensive subjects Hypertension 1995; 25: 986–993

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A human Na+/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension;Proceedings of the National Academy of Sciences;2007-11-13

2. Transient receptor potential channels in essential hypertension;Journal of Hypertension;2006-06

3. Na+/Mg2+ exchange is functionally coupled to the insulin receptor;Journal of Cellular Physiology;2004

4. Insulin Resistance and Cardiovascular Disease: New Insights from Genetics;Cardiovascular Pharmacogenetics;2004